Displaying drugs 12526 - 12550 of 14436 in total
Bevufenogene nofeparvovec
Experimental
Sesiclenegene cosaparvovec
Investigational
Peboctocogene camaparvovec
Investigational
Aguracingene cadoparvovec
Investigational
Laruparetigene zovaparvovec
Investigational
Lixmabegagene relduparvovec
Lixmabegagene relduparvovec, formerly known as LYS-GM101, is a recombinant adeno-associated virus vector serotype rh.10 (AAVrh.10) carrying the human β-galactosidase gene (GBL1). It is under development for the treatment of GM1 gangliosidosis.
Experimental
Zorevunersen
Investigational
ALMB-0168
ALMB-0168 is a humanized connexin 43 (Cx43) monoclonal antibody being investigated for osteosarcoma.
Investigational
LSP-GR3
Investigational
Mitsugumin-53
Investigational
AMT-130
Investigational
ANX-005
Investigational
Rovanersen
Investigational
Bidridistrogene xeboparvovec
Investigational
ATYR-1940
Investigational
AVXS-201
Withdrawn
SRP-6004
A recombinant AAVrh74 gene therapy expressing the dysferlin transgene under control of a muscle-specific promoter (rAAVrh74.MHCK7.DYSF.DV).
Investigational
BMN-052
Experimental
Withdrawn
BMN-053
Experimental
Withdrawn
Autologous Hematopoietic Peripheral Blood Stem Cells
Autologous hematopoietic peripheral blood stem cells were tested in a clinical trial (NCT00424489) by Northwestern University for the treatment of refractory myasthenia gravis.
Investigational
αAβ–Gas6
αAβ–Gas6 is a chimeric fusion protein being investigated in preclinical studies as an immunotherapeutic agent for Alzheimer's disease (AD). It is made of a single chain variable fragment (scFv) of an Amyloid β (Aβ)-targeting monoclonal antibody fused with a truncated receptor binding domain of growth arrest-specific 6 (Gas6), which is...
Experimental
Matched Description: … inducer of Aβ,[A253203] which is the main component of the amyloid plaques found in individuals with AD and …
Ontorpacept
Investigational
OSE-2101
Investigational
TG01 vaccine
Investigational
Roneparstat
Investigational
Displaying drugs 12526 - 12550 of 14436 in total